|
|
|
|
November 19, 2025 -Wednesday |
|
|
|
 |
| |
|
|
2ND CRM INDUSTRY DIALOGUE 2016
Monday 24/10/2016
2nd CRM INDUSTRY DIALOGUE 2016
ENGAGING THE INDUSTRY PLAYERS: A DIALOGUE SESSION WITH CRM will be held as follows:
Day/Date : Tuesday 25 October 2016
Time : 8.30 am to 1:15 pm
Venue: Le Meridien Putrajaya
Please click here for Programme
Invited Speakers:
Encik Ahmad Shariff Hambali, Head of Licensing, Registration and Enforcement Division, Medical Device Authority (MDA)
Puan Aidahwaty M. Olaybal, Head of Scientific Branch Division, Medical Device Authority (MDA)
Puan Siti Hajar Zainal Abidin, Deputy Director, R&D and Business Services, Malaysian Investment Development Authority (MIDA)
Tuan Roslan bin Akibon, Penguasa Kastam W41 Sektor GSG, Jabatan Kastam Diraja Malaysia
Encik Jay Padasian, Senior Vice President, Healthcare, Business Development and Investement Division of Malaysia Biotechnology Corporation.
You are cordially invited to send a reporter and photographer/cameraman to cover the event.
About CRM Industry Dialogue
CRM Industry Dialogue provides an avenue for Pharmaceutical companies (sponsors) and CROs to directly convey any issues/problems/suggestions/opinions that they may have to CRM. Besides strengthening cooperation and networking between all parties, CRM also takes the opportunity to update the clinical research industry on local laws, guidelines and regulations. By bringing together these industry players, CRM uses this platform to connect with them and provide upates on its current and future activities. (Event website: http://www.clinicalresearch.my/industry-dialogue/)
About Clinical Research Malaysia
Clinical Research Malaysia (CRM) is a non-profit company wholly owned by the Government of Malaysia’s Ministry of Health. CRM was established in June 2012 to position Malaysia as a preferred global destination for industry-sponsored research (ISR) and to function as an enabler and facilitator to the industry and medical fraternity for the conduct of clinical trials.
By working with other stakeholders, CRM strives to improve the local ecosystem to support growth in ISR, facilitate the needs and requirements of industry players, grow the pool of capable investigators, support staff and trial sites, and improve their capabilities and capacities to conduct ISR.
With the Ministry of Health’s backing and clear knowledge of the local research environment, CRM is able to provide sponsors (primarily from the pharmaceutical, biotech and medical device industries) and contract research organizations (CRO) with an extensive range of services that includes feasibility studies, investigator selection, placement and development of study coordinators, management of trial budget, review of clinical trial agreements and updates on local laws, guidelines and regulations. CRM also undertakes marketing and promotional activities to build industry awareness about the opportunities for ISR in Malaysia, and create public and patient awareness of clinical trials.
Source : Clinical Research Malaysia (CRM)
FOR MORE INFORMATION, PLEASE CONTACT:
Name: Syed Hamzah Syed Noordin
Tel : 03 – 7960 5153
Email : hamzah@clinicalresearch.my
Website : http://www.clinicalresearch.my
-BERNAMA
|
|
|
|
|
|
